BACKGROUND: Effectiveness of cooling and adverse events (AEs) involving skin have not been intensively evaluated in cardiac arrest survivors treated with therapeutic hypothermia (TH) when induced and maintained with a servomechanism-regulated surface cooling system. METHODS: Retrospective review of sixty-nine cardiac arrest survivor-events admitted from April 2006-September 2008 who underwent TH using the Medivance Arctic Sun Temperature Management System. A TH database and medical records were reviewed, and nursing interviews conducted. Primary endpoint was time from initiation to target temperature (TT; 32-34 °C). Secondary endpoints were cooling rate, percentage of hypothermia maintenance phase at TT, effect of body-mass index (BMI) on rate of cooling, and AEs. RESULTS: Mean time to the target temperature (TT) was 2.78 h; 80% of patients achieved TT within 4 h; all did within 8 h. Patients were at TT for 96.7% of hypothermia maintenance; 17% of patients had >1 hourly temperature measurement outside TT range. Mean cooling rate during induction phase was 1.1 °C/h, and was not associated with BMI. Minor skin injury occurred in 14 (20%) patients; 4 (6%) were device-related. Skin injuries were associated with shock (P = 0.04), and decubitus ulcers were associated with left ventricular ejection fraction <45% (P = 0.004). AEs included shivering (94%), hypokalemia (81%), hyperglycemia (57%), pneumonia (23%), bleeding (22%), post-cooling fever (17%), and bacteremia (9%). CONCLUSIONS: The Arctic Sun Temperature Management System was an effective means of performing therapeutic hypothermia after cardiac arrest. Infrequent skin injuries were associated with vasopressor use and low ejection fraction.
BACKGROUND: Effectiveness of cooling and adverse events (AEs) involving skin have not been intensively evaluated in cardiac arrest survivors treated with therapeutic hypothermia (TH) when induced and maintained with a servomechanism-regulated surface cooling system. METHODS: Retrospective review of sixty-nine cardiac arrest survivor-events admitted from April 2006-September 2008 who underwent TH using the Medivance Arctic Sun Temperature Management System. A TH database and medical records were reviewed, and nursing interviews conducted. Primary endpoint was time from initiation to target temperature (TT; 32-34 °C). Secondary endpoints were cooling rate, percentage of hypothermia maintenance phase at TT, effect of body-mass index (BMI) on rate of cooling, and AEs. RESULTS: Mean time to the target temperature (TT) was 2.78 h; 80% of patients achieved TT within 4 h; all did within 8 h. Patients were at TT for 96.7% of hypothermia maintenance; 17% of patients had >1 hourly temperature measurement outside TT range. Mean cooling rate during induction phase was 1.1 °C/h, and was not associated with BMI. Minor skin injury occurred in 14 (20%) patients; 4 (6%) were device-related. Skin injuries were associated with shock (P = 0.04), and decubitus ulcers were associated with left ventricular ejection fraction <45% (P = 0.004). AEs included shivering (94%), hypokalemia (81%), hyperglycemia (57%), pneumonia (23%), bleeding (22%), post-cooling fever (17%), and bacteremia (9%). CONCLUSIONS: The Arctic Sun Temperature Management System was an effective means of performing therapeutic hypothermia after cardiac arrest. Infrequent skin injuries were associated with vasopressor use and low ejection fraction.
Authors: Robert W Neumar; Jerry P Nolan; Christophe Adrie; Mayuki Aibiki; Robert A Berg; Bernd W Böttiger; Clifton Callaway; Robert S B Clark; Romergryko G Geocadin; Edward C Jauch; Karl B Kern; Ivan Laurent; W T Longstreth; Raina M Merchant; Peter Morley; Laurie J Morrison; Vinay Nadkarni; Mary Ann Peberdy; Emanuel P Rivers; Antonio Rodriguez-Nunez; Frank W Sellke; Christian Spaulding; Kjetil Sunde; Terry Vanden Hoek Journal: Circulation Date: 2008-10-23 Impact factor: 29.690
Authors: David B Seder; Gilles L Fraser; Tracy Robbins; Laurel Libby; Richard R Riker Journal: Intensive Care Med Date: 2009-10-22 Impact factor: 17.440
Authors: Maaret Castrén; Per Nordberg; Leif Svensson; Fabio Taccone; Jean-Louise Vincent; Didier Desruelles; Frank Eichwede; Pierre Mols; Tilmann Schwab; Michel Vergnion; Christian Storm; Antonio Pesenti; Jan Pachl; Fabien Guérisse; Thomas Elste; Markus Roessler; Harald Fritz; Pieterjan Durnez; Hans-Jörg Busch; Becky Inderbitzen; Denise Barbut Journal: Circulation Date: 2010-08-02 Impact factor: 29.690
Authors: Michael Holzer; Marcus Müllner; Fritz Sterz; Oliver Robak; Andreas Kliegel; Heidrun Losert; Gottfried Sodeck; Thomas Uray; Andrea Zeiner; Anton N Laggner Journal: Stroke Date: 2006-06-08 Impact factor: 7.914
Authors: Niklas Nielsen; Kjetil Sunde; Jan Hovdenes; Richard R Riker; Sten Rubertsson; Pascal Stammet; Fredrik Nilsson; Hans Friberg Journal: Crit Care Med Date: 2011-01 Impact factor: 7.598
Authors: Tae Nyoung Chung; Jin Hee Kim; Bo Young Choi; Sung Phil Chung; Sung Won Kwon; Sang Won Suh Journal: Stem Cells Transl Med Date: 2014-12-29 Impact factor: 6.940
Authors: Alicia M Alcamo; Rebecca Lavezoli; Cameron Dezfulian; Dennis W Simon; Rajesh K Aneja; Robert S B Clark; Patrick M Kochanek; Ericka L Fink Journal: Ther Hypothermia Temp Manag Date: 2020-05-19 Impact factor: 1.286